Abstract:In order to further characterize the difference of gender on the clinical, pathological status, survival and its predictive factors of patients on population-based lung cancer, and to determine time trends of gender differences, we analyzed the data which had been entered into Shanghai Cancer Registry System and executed by CDC. Data on demographics, stage at diagnosis, history and survival were obtained for all patients with primary bronchogenic carcinoma registered in Shanghai cancer registry system from 2002 to 2004. The time trends of the male and female incidence in the urban population from 1972 to 2004 were assessed using APC (annual percent change) analysis. Relative survival rates based on life-table analysis methods were calculated to estimate the benefit of cancer survival by compensating for the expected difference in baseline survival rates between male and female populations. Cox multi-variance analyses were used to evaluate prognostic factors; those factors were gender, age, residential area, pathological type, stage, and hospital grade. 23196 new cases of lung cancer were diagnosed during 2002 – 2004, the female crude incidence rate was 33.73/100000, and age-adjusted rate was 30.90/100000. The male crude incidence rate and the age-adjusted rate were higher than those of female. The APC of male and female crude incidence continued to rise during the past 33 years (1.723% vs 2.036%, p ≤0.01). The male age-adjusted incidence rate in tendency to reduce was seen in the urban area (APC was -0.605%, p ≤0.01), but no change in female (APC was -0.136, p >0.05). There were more stage IV cases and adenocarcinoma in women than those of men (47.5% vs. 40.0%, 86.1% vs. 47.8%, respectively, p ≤0.05).The overall 3-year survival rates and MST were significantly higher in women than men (17.05% vs. 14.01% 0.83 year vs. 0.77 year, p ≤ 0.01). Stage-specific survival rates of women were also statistically higher than those of men for each stage (p ≤ 0.05). The 3-year survival rates and MST were also significantly higher in women adenocarcinoma than men (30.38%: 22.66%, 1.48 year: 0.98 year, p ≤0.01). Female gender was an independent positive prognostic factor (p ≤ 0.01) by a multivariate Cox analysis, other positive prognostic factors were younger, urban area, squamous cancer, early stage, high-grade hospital. Shanghai is one of the high-incidence area of lung cancer in the world. The present study confirms that women had statistically better outcomes than men in different stages of disease. The reasons behind these gender differences remain unclear. Exogenous or endogenous estrogens, gene, smoking, psychology, etc, may play roles to develop of the lung cancer in women.

[Analysis of Prognostic Factors in 541 Female Patients with Advanced Non-Small Cell Lung Cancer].

Prognostic factors for survival in a Chinese population presenting with advanced non-small cell lung cancer with an emphasis on smoking status: A regional, single-institution, retrospective analysis of 4552 patients

Analysis of Survival Data in Patients with Advanced Non-Small-Cell Lung Cancer Aged 60 Years and Over

Prognostic Factors and Clinical Features of 150 Elderly Patients with Non-Small Cell Lung Cancer

Analysis of Prognostic Factors of Sequential Treatment in 355 Patients with Advanced Non-Small Cell Lung Cancer

[A Retrospective Analysis: Comparison of the Clinical Characteristics and Prognosis in Elderly and Young Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer.].

Survival Analysis of Non-Small Cell Lung Cancer Patients with Adjuvant Chemotherapy.

Analysis of factors associated with prognosis of advanced non-small cell lung cancer

Clinical features and outcome of small cell lung cancer in female patients: a large-cohort retrospective study

Treatment and Prognostic Analysis of 1638 Patients with Non-Small Cell Lung Cancer

Prognostic Factors in Older Patients with Advanced Non-Small Cell Lung Cancer in China.

The Prognostic Analysis of Advanced Non-small Cell Lung Cancer in Elderly Patients

Analysis for the prognosis of young women with lung adenocarcinoma

Effects of prognostic factors and treatment on survival in advanced non-small cell lung cancer

Analysis of the Characteristics and Prognosis of Advanced Non-Small-Cell Lung Cancer in Older Patients

P3-243: Analysis for the prognosis of young women with lung adenocarcinoma

Study of prognostic predictors for non-small cell lung cancer

C8-02: Study of Incidences, Time Trends of Female Lung Cancer, Survivals and Its Predictive Factors on Shanghai Population

Multivariate Survival Analysis of Patients with Stage I NSCLC

Prognostic Factors of Patients with Non-Small Cell Lung Cancer:A Retrospective Analysis of 1560 Cases

[Multivariate Analysis of Prognostic Factors in the Eldly Patients with Small Cell Lung Cancer: a Study of 160 Patients].